Molecular PharmaGroup is an FDA Registered 503B Outsourcing Facility based in New Providence, New Jersey. They manufacture products from the FDA Shortage List and specialty compounds for hospitals, medical groups, and independent practitioners. The company adheres to current good manufacturing practices (cGMP) to produce sterile drug products available without a prescription for patients in acute and institutional settings. Molecular PharmaGroup focuses on quality assurance by outsourcing sterility, endotoxin, and potency testing to independent QA firms while complying with USP standards. Their licensed pharmacists operate in state-of-the-art cleanrooms and follow procedures exceeding typical pharmacy standards, ensuring compliance with the latest regulations like USP 800.